Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults
A novel Staphylococcus aureus 4-antigen vaccine (SA4Ag) is under development, comprising capsular polysaccharide serotypes 5 and 8 (CP5 and CP8) conjugated to CRM197, recombinant protein clumping factor A (rmClfA), and recombinant manganese transporter protein C (MntC). We evaluated SA4Ag safety, to...
Main Authors: | Megumi Inoue, Takuma Yonemura, James Baber, Yasuko Shoji, Masakazu Aizawa, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, Alejandra Gurtman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1496764 |
Similar Items
-
Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
by: Ingrid L Scully, et al.
Published: (2014-03-01) -
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
by: Judith Absalon, et al.
Published: (2022-01-01) -
O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide
by: Ingrid L. Scully, et al.
Published: (2018-01-01) -
A PROPOSED METHODOLOGY FOR THE CORRECTION OF THE LEAF AREA INDEX MEASURED WITH A CEPTOMETER FOR PINUS AND EUCALYPTUS FORESTS
by: Domingos Mendes Lopes, et al. -
Development and evaluation of a novel vaccine against prevalent invasive multi-drug resistant strains of Streptococcus pneumoniae
by: Rehab H. Bahy, et al.
Published: (2016-11-01)